Successful Transcatheter Arterial Radioembolization of Hepatocellular Carcinoma Via Left Internal Mammary Artery: A Case Report
Open Access
- 8 March 2022
- journal article
- research article
- Published by Springer Nature in Cureus
- Vol. 14 (3) , e22954
Abstract
Hepatocellular carcinoma (HCC) is the most common primary liver malignancy. Late-stage presentation, co-morbidities, and limited donor availability enable only a few patients to receive curative therapies. HCC is treated with liver resection and transplantation as the first line of treatment. Patients in advanced stages, on the other hand, are treated with a variety of locoregional treatments. Transarterial embolization (TAE), transarterial chemoembolization (TACE), and transarterial radioembolization (TARE) are different modalities of locoregional therapy for HCC with robust collateral circulation. One of the characteristics of HCC is that it is hypervascular, therefore, parasitic supply is not unusual. The left internal mammary artery (LIMA) is considered to be an uncommon parasitic supply in HCC. While TACE has been extensively reviewed in the literature, herein we report a successful case of TARE via the LIMA which was a safe and practical alternative for a patient with HCC.Keywords
This publication has 10 references indexed in Scilit:
- Transarterial Radioembolization (TARE) Agents beyond 90Y-MicrospheresBioMed Research International, 2018
- Hepatocellular carcinomaThe Lancet, 2018
- HEPATOCELLULAR CARCINOMA: DIAGNOSIS AND OPERATIVE MANAGEMENTABCD. Arquivos Brasileiros de Cirurgia Digestiva (São Paulo), 2017
- Clinical Presentation, Risk Factors, and Treatment Modalities of Hepatocellular Carcinoma: A Single Tertiary Care Center ExperienceGastroenterology Research and Practice, 2016
- Transcatheter arterial embolic therapies for hepatocellular carcinoma: a literature review.2014
- Efficacy and safety of transcatheter chemoembolization of the internal thoracic artery in patients with hepatocellular carcinoma.2011
- Radioembolization Results in Longer Time-to-Progression and Reduced Toxicity Compared With Chemoembolization in Patients With Hepatocellular CarcinomaGastroenterology, 2011
- Hepatocellular Carcinoma with Internal Mammary Artery Supply: Feasibility and Efficacy of Transarterial Chemoembolization and Factors Affecting Patient PrognosisJournal of Vascular and Interventional Radiology, 2007
- Transcatheter Arterial Chemoembolization of Hepatocellular Carcinoma: Prevalence and Causative Factors of Extrahepatic Collateral Arteries in 479 PatientsKorean Journal of Radiology, 2006
- Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trialThe Lancet, 2002